Atlas Trials

REAl LIfe" Observational Study on the Effectiveness of Evusheld Prophylaxis Against SARS-CoV-2 Omicron Variants in Vaccine Non-responder Immunocompromised Patients

Clinical trial NCT07473986 · COMPLETED

Trial details

NCT number
NCT07473986
Sponsor
Fondazione IRCCS Policlinico San Matteo di Pavia
Status
COMPLETED
Study type
OBSERVATIONAL
SARS-CoV-2 Omicron Variants
Start date
2022-07-08
Primary completion
2024-12-31
Enrollment
88

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.